Trial intelligence / Profile preview

Infusion Volume Effects in Daytime Surgery

NCT03924804Completed

Sponsor
China Medical University
Start
Jun 2019
Primary completion
May 2022
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of ringer's acetate in Cholecystolithiasis and thyroid nodule (3 arms), sponsored by China Medical University. Primary endpoint: Change of bladder volume. Started Jun 2019; status: completed.

02

Drugs

ringer's acetate
03

Conditions

Cholecystolithiasisthyroid nodule

Beyond the preview

Go deeper on NCT03924804.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03924804.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call